Blog

Slideshow

5 tips to reduce the liability risk of prescribing GLP-1s

Author(s):

An action plan for physicians to protect themselves against malpractice litigation related to medications like Ozempic.

As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we give five tips for physicians to protect themselves from claims related to glucagon-like peptide-1 (GLP-1) medications like Ozempic.

Max Schloemann is the founder of MEDPLI Professional Liability Insurance

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Videos
The new standard for medical malpractice: A conversation with Daniel G. Aaron, M.D., J.D.
The new standard for medical malpractice: What to watch for
The new standard for medical malpractice: A step toward ending defensive medicine?
The new standard for medical malpractice: Can doctors be liable for doing what everyone else does?
The new standard for medical malpractice: What makes a clinical guideline legally defensible?
The new standard for medical malpractice: What it means for day-to-day practice
The new standard for medical malpractice: What changed?
The new standard for medical malpractice: Why the law just changed
ACP policy update 2025: A conversation with Brian E. Outland, PhD
ACP policy update 2025 interview